The head of the department of the European Medicines Agency (EMA) said that in the coming hours the regulator will officially announce the existence of a link between the AstraZeneca vaccine and the formation of blood clots.

It is increasingly difficult to say that there is no causal relationship between the AstraZeneca vaccine and the rare thrombosis associated with low platelet counts. Obviously, it exists, Le Figaro quotes an EMA representative.

A number of European countries have temporarily suspended vaccination with the British-Swedish company AstraZeneca due to a series of reports of possible thromboembolic complications in those vaccinated. The first reports came from Austria, where one patient died ten days after vaccination and another was urgently hospitalized with pulmonary embolism.

The EMA, following an investigation, announced that the vaccine was safe and effective, and the benefits outweighed the risks. AstraZeneca itself has updated the information listed in the instructions for use of the coronavirus vaccine, pointing out potential complications.

In turn, the World Health Organization announced the need to continue vaccination with AstraZeneca, noting that venous thromboembolism is one of the most common cardiovascular diseases in the world.